Author: Tiziana Life Sciences Ltd.

Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging

April 1, 2026
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA

February 25, 2026

1 2

Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging